Development, synthesis, and 68Ga-Labeling of a Lipophilic complexing agent for atherosclerosis PET imaging
Tài liệu tham khảo
WHO, 2012
Lusis, 2000, Atherosclerosis, Nature, 407, 233, 10.1038/35025203
Shimizu, 2016, Recent advances in the development of PET/SPECT probes for atherosclerosis imaging, Nucl. Med. Mol. Imaging, 50, 284, 10.1007/s13139-016-0418-9
Kuai, 2016, High-Density lipoproteins: nature's multifunctional nanoparticles, ACS Nano, 10, 3015, 10.1021/acsnano.5b07522
Perez-Medina, 2016, In vivo PET imaging of HDL in multiple atherosclerosis models, JACC Cardiovasc. Imaging, 9, 950, 10.1016/j.jcmg.2016.01.020
Cormode, 2009, HDL as a contrast agent for medical imaging, Clin. Lipidol., 4, 493, 10.2217/clp.09.38
Cormode, 2008, An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection, Small, 4, 1437, 10.1002/smll.200701285
Cormode, 2009, Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis, Bioconjug. Chem., 20, 937, 10.1021/bc800520d
Rudd, 2002, Imaging atherosclerotic plaque inflammation with [18F]-Fluorodeoxyglucose Positron emission Tomography, Circulation, 105, 2708, 10.1161/01.CIR.0000020548.60110.76
Ferreira, 2010, Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals, Bioconjug. Chem., 21, 531, 10.1021/bc900443a
Blom, 2012, 68Ga-autoclabeling of DOTA-TATE and DOTA-NOC, Int. J. Appl. Radiat. Isot., 70, 980, 10.1016/j.apradiso.2012.03.032
Lattuada, 2011, The synthesis and application of polyamino polycarboxylic bifunctional chelating agents, Chem. Soc. Rev., 40, 3019, 10.1039/c0cs00199f
Spang, 2016, Bifunctional gallium-68 chelators: past, present, and future, Semin. Nucl. Med., 46, 373, 10.1053/j.semnuclmed.2016.04.003
Hak, 2009, A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging, Eur. J. Pharm. Biopharm., 72, 397, 10.1016/j.ejpb.2008.09.017
Dioury, 2005, Synthesis of a new tricyclic tetraazatriacetic acid as ligand for gadolinium(III), Tetrahedron Lett., 46, 611, 10.1016/j.tetlet.2004.11.133
Ferreira, 2012, 68Ga small peptide imaging: comparison of NOTA and PCTA, Bioconjug. Chem., 23, 2239, 10.1021/bc300348d
Chakravarty, 2011, Development of a nano-zirconia based 68Ge/68Ga generator for biomedical applications, Nucl. Med. Biol., 38, 575, 10.1016/j.nucmedbio.2010.10.007
Ferroud, 2008, Synthesis of a novel amphiphilic GdPCTA-[12] derivative as a potential micellar MRI contrast agent, Tetrahedron Lett., 49, 5972, 10.1016/j.tetlet.2008.07.160
Enel, 2018, Facile access to the 12-membered macrocyclic ligand PCTA and its derivatives with carboxylate, amide, and phosphinate ligating functionalities, Eur. J. Org. Chem., 2018, 1765, 10.1002/ejoc.201800066
Ortiz-Muñoz, 2009, HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property, FASEB J., 23, 3129, 10.1096/fj.08-127928
Bartneck, 2014, Therapeutic targeting of liver inflammation and fibrosis by nanomedicine, Hepatobiliary Surg. Nutr., 3, 364
Tricoci, 2015, Infusion of reconstituted high-density lipoprotein, CSL112, in patients with atherosclerosis: safety and pharmacokinetic results from a phase 2a randomized clinical trial, J. Am. Heart Assoc., 4, e002171, 10.1161/JAHA.115.002171